Clinical, virological, and immunological parameters associated with superinfection of latently with FeHV-1 infected cats

Veterinary Microbiology

Volumn 138, Issue 3-4, 2009, Pages 205-216

  Richter, Marianne ^a   Schudel, Lea ^a   Tobler, Kurt ^b   Matheis, Franziska ^a   Vögtlin, Andrea ^b   Vanderplasschen, Alain ^c   Costes, Bérénice ^c   Spiess, Bernhard ^a   Ackermann, Mathias ^b  

^a VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

GFP; Glycoprotein; Herpesvirus; Reactivation; Recombinant

Indexed keywords

GREEN FLUORESCENT PROTEIN; HERPES SIMPLEX VACCINE; HERPES SIMPLEX VIRUS 1 VACCINE; INTERFERON; NEUTRALIZING ANTIBODY; THROMBOSPONDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY TITER; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CAT DISEASE; CONTROLLED STUDY; EYE INFECTION; FEMALE; GENE DELETION; HERPES SIMPLEX VIRUS 1; HERPES VIRUS INFECTION; IMMUNOLOGICAL PARAMETERS; IMMUNOSTIMULATION; MALE; NONHUMAN; SUPERINFECTION; VACCINE PRODUCTION; VIROLOGY; VIRUS GENOME; VIRUS MUTANT; VIRUS REACTIVATION; VIRUS REPLICATION; WILD TYPE;

ANIMALS; ANTIBODIES, VIRAL; CAT DISEASES; CATS; CELL LINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FEMALE; HERPESVIRIDAE; IMMUNOSUPPRESSIVE AGENTS; MALE; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL PROTEINS; VIRUS LATENCY;

BACTERIA (MICROORGANISMS); FELID HERPESVIRUS 1; HERPESVIRIDAE;

EID: 69349094039     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2009.03.022     Document Type: Article

References (50)

1. Aboody-Guterman K.S., Pechan P.A., Rainov N.G., Sena-Esteves M., Jacobs A., Snyder E.Y., Wild P., Schraner E., Tobler K., Breakefield X.O., and Fraefel C. Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo. Neuroreport 8 (1997) 3801-3808
2. Ackermann M., and Engels M. Pro and contra IBR-eradication. Vet. Microbiol. 113 (2006) 293-302
3. Ackermann M., Longnecker R., Roizman B., and Pereira L. Identification, properties, and gene location of a novel glycoprotein specified by herpes simplex virus 1. Virology 150 (1986) 207-220
4. Beyer C.F., Hill J.M., Reidy J.J., and Beuerman R.W. Corneal nerve disruption reactivates virus in rabbits latently infected with HSV-1. Invest. Ophthalmol. Vis. Sci. 31 (1990) 925-932
5. Bracklein T., Theise S., Metzler A., Spiess B.M., and Richter M. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells. Am. J. Vet. Res. 67 (2006) 1025-1032
6. Bridgeman A., Stevenson P.G., Simas J.P., and Efstathiou S. A secreted chemokine binding protein encoded by murine gammaherpesvirus-68 is necessary for the establishment of a normal latent load. J. Exp. Med. 194 (2001) 301-312
7. Bryant N.A., Davis-Poynter N., Vanderplasschen A., and Alcami A. Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. EMBO J. 22 (2003) 833-846
8. Costes B., Thirion M., Dewals B., Mast J., Ackermann M., Markine-Goriaynoff N., Gillet L., and Vanderplasschen A. Felid herpesvirus 1 glycoprotein G is a structural protein that mediates the binding of chemokines on the viral envelope. Microbes Infect. 8 (2006) 2657-2667
9. Dawson S., and Gaskell R.M. Problems with respiratory virus vaccination in cats. Compendium of continuing education. Pract. Vet. Compend. Contin. Educ. Pract. Vet. 15 (1993) 1347-1354
10. Gaskell R., and Dawson S. Feline Respiratory Disease. In: Greene C.E. (Ed). Infectious Diseases of the Dog and Cat (1998), WB Saunders, Philadelphia 97-106
11. Gaskell R.M., and Povey R.C. Re-excretion of feline viral rhinotracheitis virus following corticosteroid treatment. Vet. Rec. 93 (1973) 204-205
12. Gaskell R.M., and Povey R.C. Experimental induction of feline viral rhinotracheitis virus re- excretion in FVR-recovered cats. Vet. Rec. 100 (1977) 128-133
13. Gaskell R.M., and Povey R.C. The dose response of cats to experimental infection with feline viral rhinotracheitis virus. J. Comp. Pathol. 89 (1979) 179-191
14. Gordon Y.J., Romanowski E., and Araullo-Cruz T. A fast, simple reactivation method for the study of HSV-1 latency in the rabbit ocular model. Invest. Ophthalmol. Vis. Sci. 31 (1990) 921-924
15. Haid C., Kaps S., Gonczi E., Hassig M., Metzler A., Spiess B.M., and Richter M. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats. Vet. Ophthalmol. 10 (2007) 278-284
16. Helps C., Lait P., Tasker S., and Harbour D. Melting curve analysis of feline calicivirus isolates detected by real-time reverse transcription PCR. J. Virol. Methods 106 (2002) 241-244
17. Hickman M.A., Reubel G.H., Hoffman D.E., Morris J.G., Rogers Q.R., and Pedersen N.C. An epizootic of feline herpesvirus, type 1 in a large specific pathogen-free cat colony and attempts to eradicate the infection by identification and culling of carriers. Lab. Anim. 28 (1994) 320-329
18. Horisberger M.A., and De Staritzky K. Expression and stability of the Mx protein in different tissues of mice, in response to interferon inducers or to influenza virus infection. J. Interferon Res. 9 (1989) 583-590
19. Horisberger M.A., Schrenk R., Staiger S., Leyvraz A.R., and Martinod S. Induction of Mx-related protein in cat peripheral blood mononuclear cells after administration of recombinant human interferon hybrid. Antiviral Res. 13 (1990) 53-59
20. Huang J., Hartley C.A., Ficorilli N.P., Crabb B.S., and Studdert M.J. Glycoprotein G deletion mutants of equine herpesvirus 1 (EHV1; equine abortion virus) and EHV4 (equine rhinopneumonitis virus). Arch. Virol. 150 (2005) 2583-2592
21. Johnson R.P., and Povey R.C. Vaccination against feline viral rhinotracheitis in kittens with maternally derived feline viral rhinotracheitis antibodies. J. Am. Vet. Med. Assoc. 186 (1985) 149-152
22. Kaashoek M.J., Straver P.H., Van Rooij E.M., Quak J., and Van Oirschot J.T. Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspects. Vet. Rec. 139 (1996) 416-421
23. Kaashoek M.J., Rijsewijk F.A., Ruuls R.C., Keil G.M., Thiry E., Pastoret P.P., and Van Oirschot J.T. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene. Vaccine 16 (1998) 802-809
24. Kaye S.B., Lynas C., Patterson A., Risk J.M., McCarthy K., and Hart C.A. Evidence for herpes simplex viral latency in the human cornea. Br. J. Ophthalmol. 75 (1991) 195-200
25. Kruger J.M., Sussman M.D., and Maes R.K. Glycoproteins gI and gE of feline herpesvirus-1 are virulence genes: safety and efficacy of a gI-gE deletion mutant in the natural host. Virology 220 (1996) 229-308
26. Mikloska Z., Sanna P.P., and Cunningham A.L. Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro. J. Virol. 73 (1999) 5934-5944
27. Nasisse M.P., Davis B.J., Guy J.S., Davidson M.G., and Sussman W. Isolation of feline herpesvirus 1 from the trigeminal ganglia of acutely and chronically infected cats. J. Vet. Intern. Med. 6 (1992) 102-103
28. Post L.E., Thomsen D.R., Petrovskis E.A., Meyer A.L., Berlinski P.J., and Wardley R.C. Genetic engineering of the pseudorabies virus genome to construct live vaccines. J. Reprod. Fertil. Suppl. 41 (1990) 97-104
29. Povey C. Feline respiratory disease - which vaccine?. Feline Pract. 7 (1977) 12-16
30. Povey R.C., and Johnson R.H. A standardized serum neutralization test for feline viral rhinotracheitis. II. The virus-serum system. J. Comp. Pathol. 79 (1969) 387-392
31. Povey R.C., and Johnson R.H. A survey of feline viral rhinotracheitis and feline picornavirus infection in Britain. J. Small Anim. Pract. 12 (1971) 233-247
32. Preston C.M., Russell J., Harris R.A., and Jamieson D.R. Herpes simplex virus latency in tissue culture cells. Gene Ther. 1 Suppl. 1 (1994) S49-50
33. Preston C.M., Harman A.N., and Nicholl M.J. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J. Virol. 75 (2001) 8909-8916
34. Remeijer L., Maertzdorf J., Buitenwerf J., Osterhaus A.D., and Verjans G.M. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. Invest. Ophthalmol. Vis. Sci. 43 (2002) 358-363
35. Richards J., and Rodan I. Feline vaccination guidelines. In: Ford R.B. (Ed). The Veterinary Clinics of North America - Small Animal Practice (2001), W.B. Saunders Company, Orlando 455-492
36. Roers A., Hochkeppel H.K., Horisberger M.A., Hovanessian A., and Haller O. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J. Infect. Dis. 169 (1994) 807-813
37. Roizman B. Herpesviridae. In: Francki R.I.B., Fauquet C.M., Knudson D.L., and Brown F. (Eds). Classification and Nomenclature of Viruses (1991), Springer, New York 103-110
38. Roizman B., Norrild B., Chan C., and Pereira L. Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Virology 133 (1984) 242-247
39. Scott F.W., and Geissinger C.M. Duration of immunity in cats vaccinated with an inactivated feline panleukopenia, herpesvirus, and calicivirus vaccine. Feline Pract. 25 (1997) 12-19
40. Scott F.W., and Geissinger C.M. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine. Am. J. Vet. Res. 60 (1999) 652-658
41. Spatz S.J., Rota P.A., and Maes R.K. Identification of the feline herpesvirus type 1 (FHV-1) genes encoding glycoproteins G, D, I and E: expression of FHV-1 glycoprotein D in vaccinia and raccoon poxviruses. J. Gen. Virol. 75 Pt 6 (1994) 1235-1244
42. Stiles J., McDermott M., Bigsby D., Willis M., Martin C., Roberts W., and Greene C. Use of nested polymerase chain reaction to identify feline herpesvirus in ocular tissue from clinically normal cats and cats with corneal sequestra or conjunctivitis. Am. J. Vet. Res. 58 (1997) 338-342
43. Tham K.M., and Studdert M.J. Antibody and cell-mediated immune responses to feline herpesvirus 1 following inactivated vaccine and challenge. Zentralbl. Veterinarmed. B 34 (1987) 585-597
44. Theil D., Derfuss T., Paripovic I., Herberger S., Meinl E., Schueler O., Strupp M., Arbusow V., and Brandt T. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am. J. Pathol. 163 (2003) 2179-2184
45. Thiry E., Meurens F., Muylkens B., McVoy M., Gogev S., Thiry J., Vanderplasschen A., Epstein A., Keil G., and Schynts F. Recombination in alphaherpesviruses. Rev. Med. Virol. 15 (2005) 89-103
46. Townsend W.M., Stiles J., Guptill-Yoran L., and Krohne S.G. Development of a reverse transcriptase-polymerase chain reaction assay to detect feline herpesvirus-1 latency-associated transcripts in the trigeminal ganglia and corneas of cats that did not have clinical signs of ocular disease. Am. J. Vet. Res. 65 (2004) 314-319
47. van Oirschot J.T., Kaashoek M.J., and Rijsewijk F.A. Advances in the development and evaluation of bovine herpesvirus 1 vaccines. Vet. Microbiol. 53 (1996) 43-54
48. Vogtlin A., Fraefel C., Albini S., Leutenegger C.M., Schraner E., Spiess B., Lutz H., and Ackermann M. Quantification of feline herpesvirus 1 DNA in ocular fluid samples of clinically diseased cats by real-time TaqMan PCR. J. Clin. Microbiol. 40 (2002) 519-523
49. Weigler B.J., Guy J.S., Nasisse M.P., Hancock S.I., and Sherry B. Effect of a live attenuated intranasal vaccine on latency and shedding of feline herpesvirus 1 in domestic cats. Arch. Virol. 142 (1997) 2389-2400
50. Yokoyama N., Maeda K., and Mikami T. Recombinant viral vector vaccines for the veterinary use. J. Vet. Med. Sci. 59 (1997) 311-322